Abstract
Type 1 diabetes (T1D) is a chronic autoimmune disease destroying the insulin-producing beta cells. Recently, stem cell therapy has been tested to treat T1D. In the present study, we aim to investigate the effects of intraperitoneal and intravenous infusion of multipotent mesenchymal stem/stromal cells (MSCs) and MSC-conditioned medium (MSC-CM) in an experimental model of diabetes, induced by multiple injections of Streptozotocin (STZ). The adipose tissue-derived MSC and MSC-CM were isolated from C57Bl/6 male mice and characterized. Later, MSC and MSC-CM were injected intraperitoneally or intravenously into mice. The blood glucose, urinary glucose, and body weight were measured, and the percentages of CD4+ CD25+ FOXP3+ T cells as well as the levels of IFN-γ, TGF-β, IL-4, IL-17, and IL-10 were evaluated. Our results showed that both intraperitoneal and intravenous infusions of MSC and MSC-CM could decrease the blood glucose, recover pancreatic islets, and increase the levels of insulin-producing cells. Furthermore, the percentage of CD4+ CD25+ FOXP3+ T cells was increased after intraperitoneal injection of MSC or MSC-CM and intravenous injection of MSCs. After intraperitoneal injection of the MSC and MSC-CM, the levels of inflammatory cytokines reduced, while the levels of anti-inflammatory cytokines increased. Together current data showed that although both intraperitoneal and intravenous administration had beneficial effects on T1D animal model, but intraperitoneal injection of AD-MSC and AD-MSC-CM was more effective than systemic administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdi R, Fiorina P, Adra CN et al (2008) Immunomodulation by mesenchymal stem cells a potential therapeutic strategy for type 1 diabetes. Diabetes 57:1759–1767. https://doi.org/10.2337/db08-0180
Aguayo-mazzucato C, Bonner-weir S (2010) Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 6:139–148. https://doi.org/10.1038/nrendo.2009.274
Alnek K, Kisand K, Heilman K et al (2015) Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes. PLoS ONE. https://doi.org/10.1371/journal.pone.0142976
Augello A, Tasso R, Negrini SM et al (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175–1186. https://doi.org/10.1002/art.22511
Bassi ÊJ, Moraes-Vieira PMM, Moreira-Sá CSR et al (2012) Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61:2534–2545. https://doi.org/10.2337/db11-0844
Boumaza I, Srinivasan S, Witt WT et al (2009) Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 32:33–42. https://doi.org/10.1016/j.jaut.2008.10.004
Brayman K (2016) Stem cell therapy to cure type 1 diabetes: from hype to hope stem cell therapy to cure type 1 diabetes : from hype to hope. Stem Cells Transl Med. https://doi.org/10.5966/sctm.2012-0116
Caplan AI, Sorrell JM (2015) The MSC curtain that stops the immune system. Immunol Lett. https://doi.org/10.1016/j.imlet.2015.06.005
Chen L, Jiang X, Yang L (2004) Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10:3016–3020
Chen QH, Liu AR, Qiu HB, Yang Y (2015) Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem Cell Res Ther. https://doi.org/10.1186/s13287-015-0025-1
Chhabra P, Brayman KL (2013) Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med 2:328–336. https://doi.org/10.5966/sctm.2012-0116
Ciccocioppo R, Cangemi GC, Kruzliak P et al (2015) Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Stem Cell Res Ther. https://doi.org/10.1186/s13287-015-0122-1
Djouad F, Charbonnier L-M, Bouffi C et al (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025–2032. https://doi.org/10.1634/stemcells.2006-0548
Du MM, Ritter T, Ceredig R, Gri MD (2011) Mesenchymal stem cell e ects on T-cell e ector pathways. Stem Cell Res Ther 2:1–9
Figliuzzi M, Cornolti R, Perico N et al (2009) Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. TPS 41:1797–1800. https://doi.org/10.1016/j.transproceed.2008.11.015
Fiorina P, Voltarelli J, Zavazava N et al (2011) Immunological Applications of Stem Cells in Type 1 Diabetes. Endocrine Reviews 32:725–754. https://doi.org/10.1210/er.2011-0008
Gao F, Chiu SM, Motan DAL et al (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. https://doi.org/10.1038/cddis.2015.327
Ghionzoli M, Cananzi M, Zani A et al (2010) Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. https://doi.org/10.1007/s00383-009-2504-x
Heidari M, Aghdaei HA, Hashemi SM (2018) The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol 233:1–13. https://doi.org/10.1002/jcp.26765
Hossein-khannazer N, Hashemi SM, Namaki S et al (2019a) Research article: The effects of dental pulp stem cell conditioned media on the proliferation of peripheral blood mononuclear cells. Immunoregulation 1:187–192
Hossein-khannazer N, Hashemi SM, Namaki S et al (2019b) Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells. Life Sci. https://doi.org/10.1016/j.lfs.2018.11.040
Institutes S, Wood R (2012) Concise review : Mesenchymal stem cells and translational medicine. Emerg Issues 1:51–58
Ionescu L, Byrne RN, van Haaften T et al (2012) Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. AJP Lung Cell Mol Physiol 303:L967–L977. https://doi.org/10.1152/ajplung.00144.2011
Jiang R (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes : a pilot study. Front Med 5:94–100. https://doi.org/10.1007/s11684-011-0116-z
Jurewicz M, Yang S, Augello A et al (2010) Hyperglycemia in experimental type 1 diabetes. Diabetes. https://doi.org/10.2337/db10-0542
Kavanagh H, Mahon BP (2011) Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy Eur J Allergy Clin Immunol. https://doi.org/10.1111/j.1398-9995.2010.02509.x
Kyurkchiev D (2014) Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 6:552. https://doi.org/10.4252/wjsc.v6.i5.552
Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103:17438–17443. https://doi.org/10.1073/pnas.0608249103
Leibacher J, Henschler R (2016) Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells mesenchymal stem/stromal cells—an update. Stem Cell Res Ther 7:7
Li Y, Liu H, Chen H, Li Y (2012) Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes. Biomed Mater Eng 22:97–103. https://doi.org/10.3233/bme-2012-0694
Liu M, Han ZC (2008) Mesenchymal stem cells : biology and clinical potential in type 1 diabetes therapy biological characterization of mesenchymal stem cells isolation and culture of human MSCs. J Cell Mol Med 12:1155–1168. https://doi.org/10.1111/j.1582-4934.2008.00288.x
Mackenzie TC, Flake AW (2001) Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27(3):601–604
Madec AM, Mallone R, Afonso G, Mrad EA (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399. https://doi.org/10.1007/s00125-009-1374-z
Neshati Z, Matin MM, Bahrami AR, Moghimi A (2010) Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. J Physiol Biochem 66:181–187. https://doi.org/10.1007/s13105-010-0013-y
Parekkadan B, Van Poll D, Suganuma K et al (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE. https://doi.org/10.1371/journal.pone.0000941
Pierro A, Eaton S, De Coppi P (2009) Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. https://doi.org/10.1007/s00383-009-2504-x
Pouya S, Heidari M, Baghaei K et al (2018) Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol 54:86–94. https://doi.org/10.1016/j.intimp.2017.11.001
Rahavi H, Hashemi SM, Soleimani M et al (2015) Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model. J Diabetes Res. https://doi.org/10.1155/2015/878535
Sciences H, Ain A, Emirates UA, Medical S (2011) Concise review : Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells. https://doi.org/10.1002/stem.556
Shim EK, Lee JS, Kim DE et al (2016) Autogenous mesenchymal stem cells from the vertebral body enhance intervertebral disc regeneration via paracrine interaction: an in vitro pilot study. Cell Transplant. https://doi.org/10.3727/096368916X691420
Sioud M, Mobergslien A, Boudabous A, Flisand Y (2011) Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int J Oncol 38:385–390. https://doi.org/10.3892/ijo.2010.869
Soleymaninejadian E, Pramanik K, Samadian E (2012) Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. https://doi.org/10.1111/j.1600-0897.2011.01069.x
Svobodova E, Krulova M, Zajicova A et al (2012) The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev 21:901–910. https://doi.org/10.1089/scd.2011.0157
Tanaka F, Tominaga K, Ochi M et al (2008) Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. https://doi.org/10.1016/j.lfs.2008.09.016
Timmers L, Lim SK, Hoefer IE et al (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6:206–214. https://doi.org/10.1016/j.scr.2011.01.001
Tse WT, Pendleton JD, Beyer WM et al (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389–397. https://doi.org/10.1097/01.TP.0000045055.63901.A9
Vija L, Farge D, Gautier J et al (2009) Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes 35:85–93. https://doi.org/10.1016/j.diabet.2008.10.003
Wagner B, Henschler R, Mesenchymal ÁÁ (2013) Fate of intravenously injected mesenchymal stem cells and significance for clinical application. Adv Biochem Eng Biotechnol 130:19–37. https://doi.org/10.1007/10_2012_155
Walter MNM, Wright KT, Fuller HR et al (2010) Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316:1271–1281. https://doi.org/10.1016/j.yexcr.2010.02.026
Wang Y, Zhang A, Ye Z et al (2009) Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant Proc. https://doi.org/10.1016/j.transproceed.2009.08.072
Wang S, Li Y, Zhao J et al (2013) Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transplant 19:538–546. https://doi.org/10.1016/j.bbmt.2013.01.001
Wang M, Liang C, Hu H et al (2016) Intraperitoneal injection (IP), intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci Rep. https://doi.org/10.1038/srep30696
Xu Y, Chen L, Wang R et al (2008) Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses 71:390–393. https://doi.org/10.1016/j.mehy.2008.03.046
Yaochite J, Caliari-Oliveira C, de Souza L et al (2015) Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. Stem Cell Res Ther 6:31. https://doi.org/10.1186/s13287-015-0017-1
Yousefi F, Ebtekar M, Soleimani M et al (2013) Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2013.07.016
Yousefi F, Ebtekar M, Soudi S et al (2016) In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett. https://doi.org/10.1016/j.imlet.2016.02.016
Zhang R, Liu Y, Yan K et al (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflamm. https://doi.org/10.1186/1742-2094-10-106
Zhao Y, Mazzone T (2010) Autoimmunity Reviews Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev 10:103–107. https://doi.org/10.1016/j.autrev.2010.08.011
Zheng ZH, Li XY, Ding J et al (2008) Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/kem284
Acknowledgements
This work was supported by research grants from Tarbiat Modarres University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All applicable national and institutional guidelines for the care and use of animals were followed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hashemi, S.M., Hassan, Z.M., Hossein-Khannazer, N. et al. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice. Inflammopharmacol 28, 585–601 (2020). https://doi.org/10.1007/s10787-019-00661-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-019-00661-x